Course of Hyperkalemia in Patients on Hemodialysis.

Bruce Spinowitz Steven N Fishbane Masafumi Fukagawa Martin Ford Nicolas Guzman Anjay Rastogi

Published in: International journal of nephrology (2022)

concentrations over 8 weeks following a hyperkalemic event. Most placebo patients remained hyperkalemic and may be at continued risk of adverse events.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
clinical trial
patient reported outcomes